产品封面图
文献支持

SIGMA S2130-100G 5-磺基水杨酸 二水合物

5965-83-3
收藏
  • ¥520
  • Sigma-Aldrich
  • S2130-100G
  • 进口
  • 2026年02月01日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 库存

      有现货

    • 英文名

      5-Sulfosalicylic acid dihydrate

    • CAS号

      5965-83-3

    • 保质期

      根据瓶身LOT号查询

    • 供应商

      浙江羽翔生物科技有限公司

    • 保存条件

      常温

    • 规格

      100G

    属性

    质量水平

    200

    产品线

    ReagentPlus®

    检测方案

    ≥99%

    mp

    105-110 °C (lit.)

    溶解性

    water: soluble 100 mg/mL, clear, colorless

    SMILES字符串

    [H]O[H].[H]O[H].OC(=O)c1cc(ccc1O)S(O)(=O)=O

    InChI

    1S/C7H6O6S.2H2O/c8-6-2-1-4(14(11,12)13)3-5(6)7(9)10;;/h1-3,8H,(H,9,10)(H,11,12,13);2*1H2

    InChI key

    BHDKTFQBRFWJKR-UHFFFAOYSA-N

    一般描述

    5-磺基水杨酸二水合物是一种多官能金属螯合配体,可用于形成金属配位络合物。

    应用


    • Efficient transfer hydrogenation of biomass-derived furfural to furfuryl alcohol over mesoporous Zr-containing hybrids: This research uses 5-sulfosalicylic acid as a ligand to enhance catalytic efficiency, demonstrating potential applications in biofuel production 

    • Synthesis of polyaniline/5-sulfosalicylic acid composite and its electrochemical properties: Investigates the synthesis of a composite material that exhibits promising electrochemical properties, useful for developing advanced electronic materials

    • Controllable 5-sulfosalicylic acid assisted solvothermal synthesis of monodispersed superparamagnetic Fe3O4 nanoclusters: Highlights the role of 5-sulfosalicylic acid in controlling the size and dispersion of magnetic nanoparticles, crucial for various technological applications

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    In vitro protective effects of plants frequently used traditionally in cancer prevention in Thai traditional medicine: An ethnopharmacological study.

    Journal of ethnopharmacology (2019-11-22)
    Natchagorn Lumlerdkij, Ranida Boonrak, Suksalin Booranasubkajorn, Pravit Akarasereenont, Michael Heinrich
    PMID31751648
    摘要

    Thai traditional medicine (TTM) has been used widely in cancer management in Thailand. Although several Thai medicinal plants were screened for pharmacological activities related to cancer treatment, such evidence still suffers from the lack of linking with TTM knowledge. To document knowledge and species used in cancer prevention in TTM and to preliminary investigate pharmacological activities related to the documented knowledge of twenty-six herbal drugs used in cancer/mareng prevention. Fieldwork gathering data on TTM concept and herbal medicines used in cancer prevention was performed with TTM practitioners across Thailand. Later, water and ethanol extracts from twenty-six herbal drugs mentioned as being used in cancer prevention were screened for their protective effect against tert-butyl hydroperoxide-induced cell death in HepG2 cells. Then active extracts were investigated for their effects on NQO1 activity, glutathione level, and safety in normal rat hepatocytes. The fieldwork helped in the development of TTM cancer prevention strategy and possible experimental models to test the pharmacological activities of selected medicinal plants. Fifteen plant extracts showed significant protective effect by restoring the cell viability to 40-59.3%, which were comparable or better than the positive control EGCG. Among them, ethanol extracts from S. rugata and T. laurifolia showed the most promising chemopreventive properties by significantly increased NQO1 activity, restored GSH level from oxidative damage, as well as showed non-toxic effect in normal rat hepatocytes. TTM knowledge in cancer prevention was documented and used in the planning of pharmacological experiment to study herbal medicines, especially in cancer, inflammation, and other chronic diseases. The proposed strategy should be applied to in vivo and clinical studies in order to further confirm the validity of such a strategy. Other traditional medical systems that use integrated approaches could also apply our strategy to develop evidence that supports a more rational uses in traditional medicine.

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1
    上海远慕生物科技有限公司
    2025年07月08日询价
    询价
    青岛捷世康生物科技有限公司
    2026年01月17日询价
    ¥72
    上海梵态生物科技有限公司
    2025年07月16日询价
    询价
    上海谷研实业有限公司
    2025年07月11日询价
    ¥247
    上海源叶生物科技有限公司
    2025年10月29日询价
    文献支持
    SIGMA S2130-100G 5-磺基水杨酸 二水合物 5965-83-3
    ¥520